HK$2.54
HK$0.00 (0.00%)
End-of-day quote: 05/23/2024
SEHK:1061
Essex Bio-Technology Annual Report
| Year | Year | 2021 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
HK$1.64B | HK$1.18B | HK$899.59M | HK$775.66M | HK$654.01M | |
| GM % | Gross Margin % |
|
85.23% | 82.75% | 81.99% | 80.32% | 80.98% | |
| OM | Operating Margin |
|
24.05% | 23.43% | 22.19% | 21.23% | 20.25% | |
| EPS | Earnings Per Share |
|
HK$0.00 | HK$0.58 | HK$0.39 | HK$0.29 | HK$0.24 | HK$0.19 |
| Div. | Dividends |
|
HK$0.00 | HK$0.06 | HK$0.00 | HK$0.03 | HK$0.03 | |
| PR % | Payout Ratio % |
|
0 | 15.38% | 0 | 12.50% | 15.79% | |
| Sha. | Shares |
|
575.56m | 578.75m | 563.49m | 562.15m | 559.54m | |
| OCF | Operating Cash Flow |
|
HK$409.16M | HK$200.87M | HK$193.72M | HK$90.21M | HK$68.64M | |
| FCF | Free Cash Flow |
|
HK$319.11M | HK$179.58M | HK$183.35M | HK$78.44M | HK$57.26M | |
| FCFS | Free Cash Flow Per Share |
|
HK$0.27 | HK$0.17 | HK$0.22 | HK$0.10 | HK$0.08 |
